Showing results (1-10 of 55) with videos related to
Sort By:
Pageof 6
Cornea|December 19, 2006
Systemic tacrolimus in the treatment of severe atopic keratoconjunctivitisThomas Stumpf, Nabeel Luqmani, Peter Sumich, et al.Plos One|April 3, 2008
Erythropoietin: a potent inducer of peripheral immuno/inflammatory modulation in autoimmune EAERuiRong Yuan, Yasuhiro Maeda, Weiping Li, et al.Annals of Neurology|November 25, 2004
Beneficial effect of erythropoietin on experimental allergic encephalomyelitisWeiping Li, Yasuhiro Maeda, Rui Rong Yuan, et al.American Journal of Ophthalmology|July 31, 2003
Autoimmune optic neuropathy with anticardiolipin antibody mimicking multiple sclerosis in a childLarry Frohman, Roger Turbin, Leonard Bielory, et al.Journal of Neuroscience Research|July 12, 2002
Apoptotic death following Fas activation in human oligodendrocyte hybrid culturesWeiping Li, Yasuhiro Maeda, Xue Ming, et al.Neurology|July 31, 2016
MTR recovery in brain lesions in the BECOME study of glatiramer acetate vs interferon β-1bRobert A Brown, Sridar Narayanan, Nikola Stikov, et al.Plos One|July 10, 2008
Variants of ST8SIA1 are associated with risk of developing multiple sclerosisSeema Husain, Cagri Yildirim-Toruner, Justin P Rubio, et al.Neurology|July 21, 2017
MRI evidence of acute inflammation in leukocortical lesions of patients with early multiple sclerosisJosefina Maranzano, David A Rudko, Kunio Nakamura, et al.Therapeutic Advances in Neurological Disorders|February 6, 2018
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing-remitting multiple sclerosis: the CLARITY Extension studyGiancarlo Comi, Stuart Cook, Kottil Rammohan, et al.Drug Safety|May 25, 2020
Pregnancy Outcomes During the Clinical Development Program of Cladribine in Multiple Sclerosis: An Integrated Analysis of SafetyGavin Giovannoni, Andrew Galazka, Regina Schick, et al.Pageof 6